[Therapy of an experimentally induced radiation syndrome in the rat using brain phospholipids and an antifibrinolytic agent (AMCHA)].
D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D004338:Drug Combinations; D006470:Hemorrhage / Q000188:drug therapy; D008297:Male; D011833:Radiation Injuries, Experimental / Q000188:drug therapy*; D051381:Rats; D013577:Syndrome; D013925:Thromboplastin / Q000494:pharmacology / Q000627:therapeutic use*
D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D004338:Drug Combinations; D013925:Thromboplastin
Die Behandlung des experimentellen hämorrhagischen Strahlungssyndroms der Ratte mit Hirnphospholipiden und einem Antifibrinolytikum (AMCHA.